Aline Barth - Global Blood Therapeutics

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 25 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Artificial Intelligence: From Buzzword to Useful Tool in Clinical Pharmacology

Mohamed H. Shahin,Aline Barth,Jagdeep T. Podichetty,Qi Liu, Navin Goyal,Jin Y. Jin,Daniele Ouellet

CLINICAL PHARMACOLOGY & THERAPEUTICSno. 4 (2024): 698-709

引用0浏览0WOS引用

A Phase 1 Study in Healthy Participants to Characterize the Safety and Pharmacology of Inclacumab, a Fully Human Anti-P-selectin Antibody, in Development for Treatment of Sickle Cell Disease

Christina Lourdes Mayer,Kathleen Koeck, Margot Hottmann,Andrew Redfern,Mark Davis,Aline Barth,Xin Geng,Carolyn Hoppe,Patrick Yue

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY（2023）

引用0浏览0WOS引用

Clinical Assessment of Gepotidacin (GSK2140944) As a Victim and Perpetrator of Drug–drug Interactions Via CYP3A Metabolism and Transporters

Aline Barth,Caroline R. Perry,Shaila Shabbir,Maciej J. Zamek-Gliszczynski,Sebin Thomas,Etienne F. Dumont,Darin B. Brimhall,Dung Nguyen,Meenakshi Srinivasan,Brandon Swift

CTS-CLINICAL AND TRANSLATIONAL SCIENCE（2023）

引用1浏览0WOS引用

Pharmacokinetic, Safety, and Tolerability Evaluations of Gepotidacin (GSK2140944) in Healthy Japanese Participants

Aline Barth,Mohammad Hossain,Caroline R. Perry,Annette S. Gross,Hirofumi Ogura,Shaila Shabbir,Sebin Thomas,Etienne F. Dumont,Darin B. Brimhall,Meenakshi Srinivasan,Brandon Swift

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT（2023）

引用1浏览0WOS引用

Population Pharmacokinetic Modeling of Different Formulations of Inclacumab Using Phase 1 Data in Healthy Participants

Kashyap Patel, Jiawei Zhou,Stefanie Hennig, Christina Lourdes Mayer,Kathleen Koeck,Helen Kastrissios,Patanjali Ravva,Aline Barth

BLOOD（2023）

引用0浏览0引用

Artificial Intelligence: from Buzzword to Useful Tool in Clinical Pharmacology

Mohamed H. Shahin,Aline Barth,Jagdeep T. Podichetty, Qi Liu, Navin Goyal,Jin Y. Jin,Danièle Ouellet

Clinical pharmacology and therapeutics/Clinical pharmacology & therapeuticsno. 4 (2023): 698-709

引用0浏览0引用

Dose Selection for Phase III Clinical Evaluation of Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections

Nicole E Scangarella-Oman,Mohammad Hossain,Jennifer L Hoover,Caroline R Perry,Courtney Tiffany,Aline Barth,Etienne F Dumont

Antimicrobial agents and chemotherapy（2022）

引用20浏览0WOS引用

Design and Measurement of Drug Tissue Concentration Asymmetry and Tissue Exposure-Effect (Tissue PK-PD) Evaluation

Richard Zang,Aline Barth,Harvey Wong,Jan Marik, Jie Shen,Julie Lade,Kerri Grove,Matthew R. Durk,Neil Parrott,Patrick J. Rudewicz,Sylvia Zhao, Tao Wang,Zhengyin Yan,Donglu Zhang

JOURNAL OF MEDICINAL CHEMISTRY（2022）

引用5浏览0WOS引用

Comparison between physiologically based pharmacokinetic and population pharmacokinetic modelling to select paediatric doses of gepotidacin in plague

Dung Nguyen,Jafar Sadik Shaik,Guoying Tai,Courtney Tiffany,Caroline Perry,Etienne Dumont,David Gardiner,Aline Barth,Rajendra Singh,Mohammad Hossain

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY（2022）

引用7浏览0WOS引用

Pharmacokinetics of Oral Formulations of Gepotidacin (GSK2140944), a Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor, in Healthy Adult and Adolescent Participants

Aline Barth,Mohammad Hossain,Darin B. Brimhall,Caroline R. Perry,Courtney A. Tiffany,Sherry Xu,Etienne F. Dumont

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY（2022）

引用11浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn